$ELMGF $ELEM.C Element79 Gold Corp Secures Reclamation Bond

New Post Public Reply Private Reply Replies (0) Message Board
louied91
72
$ELMGF $ELEM.C Element79 Gold Corp Secures Reclamation Bond Approval for Gold Mountain Exploration Project

https://www.thenewswire.com/press-releases/1B...oject.html

Vancouver, BC — October 21 2025 — TheNewswire - Element79 Gold Corp (CSE:ELEM, OTC:ELMGF, FSE: 7YS0)(the “Company” or “Element79”) is elated to announce a major step forward in its U.S. exploration strategy. The Bureau of Land Management (BLM) Nevada State Office has officially accepted a reclamation bond of USD $19,871 for its Gold Mountain Exploration Project This approval represents a key regulatory milestone, paving the way for expanded exploration and operational activity.

The bond, registered as of October 14, 2025, was received October 20, 2025. This confirms Element79’s compliance with financial assurance requirements for surface reclamation activities — a crucial component of responsible resource development.

“This bond approval is more than just a procedural step — it’s a green light for growth, we are also excited to see its approval given the recent government shut down.” said Michael Smith, The Companies CEO. “With this in place, Element79 can move forward with confidence on our phase one drill program on Gold Mountain, knowing our environmental responsibilities are fully secured and regulatory boxes checked. We have been working with tendering earthworks and drilling teams while waiting for this approval, and now we can begin engaging them for site work and drilling this fall. This brings us one step closer to unlocking the value at Gold Mountain, in Battle Mountain, of Nevada.”

Element79 remains committed to responsible resource development, and creating lasting value for its shareholders.

Element79 Gold Corp. (ELMGF) Stock Research Links

ELMGF Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Hims & Hers Health Faces Revenue Challenges and Legal Issues

Updated Category News Views 246

Hims & Hers Revenue Challenges Amid Stock Decline In recent trading sessions, Hims & Hers Health reported notable stock fluctuations as the company unveiled a decline in revenue per customer linked to its customization of GLP-1 medications for weight loss. This announcement caused an almost 11% drop in the stock price. Impacts of Collaboration Termination This steep...

Continue Reading
Entrée Resources Reports Solid Results for Q3 2025

Updated Category News Views 166

Entrée Resources Ltd. Overview Entrée Resources Ltd. (TSX: ETG; OTCQB: ERLFF), a reputable Canadian mining company focused on the Oyu Tolgoi project, has announced its interim financial results for the third quarter of 2025. This announcement sheds light on its ongoing operations and future plans, emphasizing the company's significant role in one of the world's largest...

Continue Reading
Bucket List Wine Dinners Beckon to Los Angeles

Updated Category News Views 10

Sipping on the Extraordinary: LA Wine Soiree When was the last time you had a glass of wine that truly feels like you've unlocked a treasure chest? That's what LearnAboutWine.com is going for with their bucket list wine dinners in Los Angeles. Imagine tasting some of the world's most coveted bottles, all served with a level of polish that screams high-end dining. Led by...

Continue Reading
BioLife Solutions Enhances Growth Potential with $73 Million Sale

Updated Category News Views 68

BioLife Solutions Announces $73 Million Sale of SciSafe In a significant move aimed at reinforcing its strategic direction, BioLife Solutions, Inc. (NASDAQ: BLFS), a prominent player in the development and supply of cell processing tools and services for the cell and gene therapy market, has announced the sale of its biostorage subsidiary, SciSafe Holdings, Inc. The...

Continue Reading
Advancements in Universal Vaccine Development by Dx&Vx

Updated Category News Views 154

Innovative Pathway Towards a Universal COVID-19 Vaccine In the wake of a global resurgence of COVID-19, Dx&Vx (DXVX) is stepping up its efforts to develop a universal vaccine aimed at providing protection against all variants of the virus. With the recent acquisition of cutting-edge technology, this next-generation vaccine is set to attract significant global interest....

Continue Reading